This study presents evidence that phosphoinositide 3-kinase (PI3K) plays a concerted role with phospholipase C␥ in initiating antigen-mediated Ca 2؉ signaling in mast cells via a phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P 3 )-sensitive Ca 2؉ entry pathway. Exogenous PI(3,4,5)P 3 at concentrations close to its physiological level induces instantaneous Ca 2؉ influx into RBL-2H3 cells. This PI(3,4,5)P 3 -induced intracellular Ca 2؉ increase is independent of phospholipase C activity or the depletion of internal stores. ) and diacylglycerol, which induce the release of Ca 2ϩ from intracellular stores and the activation of protein kinase C, respectively. On the other hand, stimulation of PI3K results in transient accumulation of micromolar levels of phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P 3 ) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P 2 ). Although the involvement of PI3K in antigen-induced degranulation is established (7-11), a clear consensus regarding how lipid products derived from the action of PI3K mediate the cellular responses has yet to emerge. Putative downstream targets for PI(3,4,5)P 3 and PI(3,4)P 2 include SH2-or pleckstrin homology (PH) domain-containing signaling enzymes such as PLC-␥, Akt, and Bruton's tyrosine kinase (Btk) (12, 13), which transduce the signal to the respective signaling pathways. In addition, data from several laboratories suggest a role of PI3K in the regulation of intracellular Ca 2ϩ ([Ca 2ϩ ] i ) increase in mast cells (9,11,14). Evidence suggests that PI3K may mediate [Ca 2ϩ ] i elevation in mast cells via two distinct mechanisms. First, in vitro data indicate that PI(3,4,5)P 3 stimulates Ins(1,4,5)P 3 production by activating PLC␥ isozymes (15,16). This PLC␥ activation may be attained directly by facilitating membrane translocation (15, 16) or indirectly via Btk (14, 17). Second, PI3K may increase [Ca 2ϩ ] i by facilitating Ca 2ϩ mobilization across plasma membranes (11). This premise was prompted by data showing the inhibitory effect of PI3K inhibitors on antigen-induced Ca 2ϩ response (9,11,14), and is in * This work was supported by National Institutes of Health Grant GM53448. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.‡ To whom correspondence should be addressed: College of Pharmacy, The Ohio State University, 500 West 12th Ave., Columbus, OH 43210-1291. Tel.: 614-688-4008; Fax: 614-688-8556; E-mail: chen@ dendrite.pharmacy.ohio-state.edu.1 The abbreviations used are: Fc⑀RI, the high affinity receptor for IgE; PI3K, phosphoinositide 3-kinase; PLC, phospholipase C; PI(3,4,5)P 3 , phosphatidylinositol 3,4,5-trisphosphate; PI(3,4)P 2 , phosphatidylinositol 3,4-bisphosphate; PI(4,5)P 2 , phosphatidylinositol 4,5-bisphosphate; PI(3)P, phosphatidylinositol 3-monophosphate; Ins(1,4,5)P 3 , D-myo-inositol 1,4,5-trisphosphate; Ins(1,3,4,5)P 4 , Dmyo-inositol 1,3,4...